Cancer remains a leading cause of death globally, and its complexity poses a significant
challenge to effective treatment. Cancer stem cells and their markers have become key …

The role of tumor interaction with stromal components during carcinogenesis is crucial for
the design of efficient cancer treatment approaches. It is widely admitted that tumor hypoxic …

Tumor stemness is associated with the recurrence and incurability of colorectal cancer
(CRC), which lacks effective therapeutic targets and drugs. Glycinamide ribonucleotide …

Hepatocellular carcinoma (HCC) is a prevalent malignant cancer worldwide, characterized
by high morbidity and mortality rates. Alpha-fetoprotein (AFP) is a glycoprotein synthesized …

Histone lysine lactylation (Kla) plays a vital role in the tumorigenesis of hepatocellular
carcinoma (HCC). Hence, we focused on Kla-specific genes to select novel therapeutic …

Recent studies suggest that Rab11-family interacting proteins (Rab11-FIPs) play an
important role in tumorigenesis and progression. Among the Rab11-FIPs, Rab11-FIP4 has …

Background Extensive evidence links Clonorchis sinensis (C. sinensis) to
cholangiocarcinoma; however, its association with hepatocellular carcinoma (HCC) is less …

Triple-negative breast cancer (TNBC) stands out as the most aggressive subtype within the
spectrum of breast cancer. The current clinical guidelines propose treatment strategies …

Simple Summary Hepatocellular carcinoma (HCC) remains one of the leading causes of
cancer mortality. Treatment of HCC remains challenging, especially for those with advanced …

Hepatocellular carcinoma (HCC), the sixth most common cancer worldwide, is associated
with a high degree of malignancy and poor prognosis. Patients with early HCC may benefit …